Juntendo Medical Journal 72(1), 2026 Original Articles Juntendo Medical Journal 2026. 72(1), 127-133 Association Between Bleeding Severity and Quality of Life in Adults with Immune Thrombocytopenia Marvelous POPOOLA1), Sharmeen MALIK2), Kaushalendra Mani TRIPATHI3), Ashok KUMAR4), Irem KARATAS5), Muhammad Muneeb KHAN6), Basil KHALIL7), Shough ALHARATA7), Farah SALEH8), Sidra HARISS9), Majd Aldin OUDEH10), Hiba MANAF11), Khuzami Moaied Rashad ODEH12) 1)Department of Emergency Medicine, Calvary Adelaide Hospital, Adelaide, Australia 2)Department of Medicine, Holy Family Hospital, Rawalpindi, Pakistan 3)Department of Medicine, White River Medical Center - White River Health, Batesville, USA 4)Department of Emergency Medicine, Lifecare Hospital, Abu Dhabi, UAE 5)Department of Acute Medicine, Kingston and Richmond NHS Foundation Trust, London, United Kingdom 6)Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan 7)Department of Medicine, Istanbul Okan University, Istanbul, Turkey 8)Department of General Practice, Gulf Medical University, Ajman, UAE 9)Department of General Practice, Thumbay University Hospital, Ajman, UAE 10)Department of Medicine, Odessa National Medical University, Odessa, Ukraine 11)Department of Clinical Sciences, Thumbay University Hospital, Ajman, UAE 12)Department of General Practice, Ministry of Health Hospitals, Irbid, Jordan Objectives: Immune thrombocytopenia (ITP) is a disorder that is characterised by a low count of platelets and an increased risk of bleeding. It can cause symptoms which affect normal functioning and well-being. The study has discussed how bleeding severity is linked to the quality of life (QOL) of ITP patients in adulthood. Materials and Methods: A cross-sectional study was done to examine 300 patients with primary ITP admitted to tertiary care hospitals. Bleeding severity was measured with the help of the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT), and HRQoL was measured with the help of the WHOQOL-BREF. The data were analysed using Pearson's correlation, t-tests, ANOVA, and multiple linear regression. Results: Most participants (92.7%) were female, with a mean age of 49.8. Overall, HRQoL showed a significant negative correla­ tion with bleeding severity (r = -0.42, p < 0.001). Women had higher bleeding scores (p < 0.001) and lower HRQoL scores (p = 0.017) than men. Worse bleeding and lower HRQoL were linked to older age (p < 0.001). Regression analysis revealed bleeding severity (β = -0.32, p = 0.001), female gender, old age, prolonged disease duration, frequent bleeding episodes, hospi­ talisation, and comorbidity as significant predictors of worse HRQoL. Conclusion: Adults with ITP have a worse quality of life in relation to greater bleeding severity. The holistic treatment that is concerned not only with the physical condition, but also with the emotional needs can contribute to the general welfare. Key words: immune thrombocytopenia, bleeding severity, quality of life, WHOQOL-BREF, ISTH-BAT Corresponding author: Muhammad Muneeb Khan Department of Medicine, Hayatabad Medical Complex HMC, Phase-4 Phase 4, Hayatabad, Peshawar, Pakistan TEL: +92-345-7783691 〔Received E-mail: muhammadmuneebk66@gmail.com Nov. 16, 2025〕 〔Accepted Nov. 25, 2025〕 J-STAGE Advance published date: Feb. 10, 2026 Copyright © 2026 The Juntendo Medical Society. This is an open access article distributed under the terms of Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original source is properly credited. doi: 10.14789/ejmj.JMJ25-0055-OA 127 Popoola M, et al: Bleeding severity and quality of life in ITP Introduction Immune thrombocytopenia (ITP) is an autoim­ mune disease characterised by isolated thrombocy­ topenia due to heightened platelet destruction and reduced platelet production. It can be primary or secondary and can happen in people of all ages, with bleeding as the most prevalent clinical manifesta­ tion1, 2). ITP occurs at a rate of about 2-4 per 100,000 adults3). The bleeding in ITP can range from mildly bruised to life-threatening intracranial haemorrhage. There is a sharp rise in the risk of bleeding with very low platelet counts, especially below 20 × 109/L, and severe or mucosal bleeding is associated with extre­ mely low levels and the use of anticoagulant drugs4, 5). ITP causes significant loss in health-related quality of life (HRQoL), whereby the patients are usually fatigued, have a fear of bleeding and experience social or occupational restrictions. Recent research highlights the importance of patient-reported outc­ omes6). Fatigue was strongly associated with dimin­ ished HRQoL in the physical and mental domains7). In general, ITP and its management have signifi­ cant influences on patients' HRQoL, particularly in chronic cases. Factors such as low platelet count, anaemia, bleeding severity, and various treatments can deteriorate QOL, underscoring the importance of holistic care aimed at enhancing well-being8, 9). Given that there is limited literature on the devel­ oping world, particularly South Asian clinical prac­ tice, it would be necessary to find out the effect of bleeding symptoms on QoL among adults with ITP. The study aims to establish the association between HRQoL and bleeding severity in adults with ITP. Identifying such a connection may help clinicians develop more comprehensive management strate­ gies to address the disease's psychosocial and phys­ ical aspects. Materials and Methods Study design and setting The study is a cross-sectional observational study of patients with ITP who visited haematology outpa­ tient clinics at tertiary care hospitals. Data collec­ tion was conducted over 7 months following institu­ tional review board approval. 128 Study population and sampling The study population consisted of 300 patients with confirmed primary ITP. The sample size was calculated using the correlation studies formula, with a 95% confidence level and a 5% margin of error. Participants were recruited through conve­ nience sampling. The inclusion criteria were adults aged 18 years or older with a history of ITP for at least 3 months. Patients with secondary thrombocytopenia, comorbid hematologic or severe psychiatric illness were excluded. Informed consent was obtained in writing from all participants before data collection. Data collection tools Demographic and clinical proforma Demographic and clinical factors, including age, gender, education, length of illness, current treat­ ment, and comorbidities, were recorded using a structured proforma. ISTH-BAT (International society on thrombosis and haemostasis - bleeding assessment tool) The severity of bleeding was assessed by the ISTH-BAT, created by the Scientific and Standard­ isation Committee (SSC) of the International Society on Thrombosis and Haemostasis in 2010. The ISTHBAT consists of 14 types of bleeding, including epistaxis, cutaneous bleeding, oral cavity bleeding, gastrointestinal bleeding, and surgical bleeding, with a score of 0 to 4 (0 = no bleeding, 1-2 = mild/ moderate, 3 4 = severe). The cumulative score is the bleeding phenotype of the individual. The highest possible score is 56, and the higher the score, the more severe the tendency toward bleeding10). WHOQOL-BREF (World health organisation quality of life - BREF) The WHOQOL-BREF, developed by the World Health Organisation Quality of Life group in 1996, was used to measure QOL. The questionnaire consists of 26 questions and covers four areas: physical health, psychological health, social relationships, and environment. Individual items are rated using a 5-point Likert rating scale (1 = very poor, 5 = very good). Raw domain scores are transformed to a 0-100 scale, with higher scores indicating a better quality of life11). Juntendo Medical Journal 72(1), 2026 Procedure Face-to-face interviews with trained researchers were conducted in a private setting where data were collected and confidentiality was maintained. All questionnaires were completed during a single visit, and each session lasted about 20-25 minutes. The records were collected anonymously and stored in secure locations. Data analysis The statistical analysis was conducted using the Statistical Package for the Social Sciences (SPSS) version 26.0. A descriptive summary of the partici­ pants' characteristics was presented using frequen­ cies and percentages. Pearson's correlation and independent t-tests were used to examine the relationship between bleeding severity (ISTHTable 1 Variable BAT scores) and quality of life (WHOQOL-BREF domains). A p-value less than 0.05 was taken to be statistically significant. Ethical considerations The Holy Family Hospital, Rawalpindi, ethics committee granted ethical permission (HFH/ERC2025-A/09-147). Participation was voluntary, and all participants provided informed written consent before enrolment. The research process was done in a highly confidential and anonymous manner. Demographic characteristics of participants (N = 300) A total of 300 participants were included in the study, as indicated in Table 1, most of them female (92.7%), with the 50-59 age group being the most Demographic characteristics of participants (N = 300) f (N) % f (N) % 18-29 years 40 13.3 Less than 6 months 40 13.3 30-39 years 55 18.3 6-12 months 77 25.7 40-49 years 70 23.3 1-3 years 106 35.3 50-59 years 80 26.7 3-5 years 58 19.3 60 years or above 55 18.3 More than 5 years 19 6.3 44 14.7 Age Variable Duration since ITP diagnosis Gender Current treatment Male 22 7.3 No treatment/watchful waiting Female 278 92.7 Corticosteroids 78 26.0 IVIG (Intravenous Immuno-globulin) 85 28.3 Marital status Single 45 15.0 Married 100 33.3 Thrombopoietin receptor agonists (e.g., eltrombopag, romiplostim) 68 22.7 Divorced 113 37.7 Splenectomy 25 8.3 Widowed 42 14.0 Frequency of bleeding episodes (past 6 months) Educational level None 108 36.0 No formal education 12 4.0 Occasional (1-2 times) 108 36.0 Primary 49 16.3 Moderate (3-5 times) 58 19.3 Secondary 87 29.0 Frequent (more than 5 times) 26 8.7 Undergraduate 88 29.3 Any hospitalisation due to bleeding? Graduate or above 64 21.3 Yes 160 53.3 No 140 46.7 Employment status Student 98 32.7 Presence of other chronic illness Employed 21 7.0 None 48 16.0 Home-maker 70 23.3 Hypertension 113 37.7 Unemployed 84 28.0 Diabetes 98 32.7 Retired 27 9.0 Heart disease 41 13.7 Note. f = frequency, % = percentage; Values are presented as N (%), N = 300; No statistical comparisons were performed for demographic variables in this table. 129 Popoola M, et al: Bleeding severity and quality of life in ITP (ISTH-BAT: 235.5 ± 12.5), and males had milder bleeding. Conversely, the overall QOL was observed to be poorer in the case of females (WHOQOLBREF: 75.5 ± 6.5) when compared with that of males (72.0 ± 8.0; t = 2.42, p = 0.017, Cohen d = 0.46). significant (26.7%). The vast majority of partici­ pants were divorced (37.7%) or married (33.3%), and had secondary-level education or higher (58.6% combined). Regarding employment, 32.7% were students, and 28.0% were not employed. Most of them had 1-3 years of ITP diagnosis (35.3%). The most prevalent treatments currently were IVIG (28.3) and corticosteroids (26.0), and 14.7% had no treatment. More than half experienced bleeding in at least one hospitalisation (53.3%), and 36.0% had occasional bleeding episodes within the last six months. The most prevalent comorbidities were hypertension (37.7%) and diabetes (32.7%), whereas 16.0% did not use any other chronic illness. Age-related differences in bleeding severity and quality of life According to Table 4, participants showed signif­ icant age-related differences in quality of life and bleeding severity. Bleeding (ISTH-BAT) was more severe in the 60+ years group (240.0 ± 12.0) compared to the 18-29 years age group (220.0 ± 8.0) (F = 12.30, p = 0.001, 0.142). Conversely, the overall QOL (WHOQOL-BREF) deteriorated with age, ranging from 76.0 ± 6.0 to 68.0 ± 8.5 (F = 6.30, p < 0.001, η 2 = 0.079), indicating that older respondents reported more bleeding and lower perceived well-being. Correlation between bleeding severity and quality of life As indicated in Table 2, there was a strong nega­ tive relationship between bleeding severity (ISTHBAT) and overall quality of life (WHOQOL-BREF) scores (r = -0.420, p < 0.001). This shows that the participants who had more severe bleeding had a lower quality of life in physical, psychological, social, and environmental areas. Multiple regression predicting QOL from bleeding severity and clinical factors In participants with ITP, as indicated in Table 5, multiple linear regression analysis shows several significant predictors of quality of life (WHOQOLBREF). Lower quality of life was linked to higher bleeding severity (ISTH-BAT) (β = 0.320 = -0.001). Also, female gender (β = -0.110, p = 0.006), older age (β = -0.180, p < 0.001), longer disease time (β = -0.120, p = 0.002), more frequent bleeding episodes (β = -0.200, p < 0.001), bleeding hospitalizations (β = -0.130, p = 0.003), and other chronic illnesses (β Gender differences in bleeding severity and quality of life Table 3 shows that quality of life and bleeding severity differed significantly by gender. Females (225.0 ± 10.5) scored higher than males (235.5 ± 12.5) in terms of mean bleeding severity scores Table 2 Correlation Between Bleeding Severity (ISTH-BAT) and quality of life (WHOQOL-BREF) among adults with immune thrombocy­ topenia (N = 300) Variables r t(df) p Total ISTH-BAT - - - -0.420** -7.99 (298) <0.001** Total WHOQOL-BREF Note. Values represent Pearson correlation coefficients (r) between continuous variables; N = 300; p < 0.001 (2-tailed) was considered statistically significant and is denoted with double asterisks (**). Table 3 Gender differences in bleeding severity and quality of life among patients (N = 300) Variables Male (N=22; 7.3%); (M ± SD) Female (N=278; 92.7%); (M ± SD) t p 95% CI LL 95% CI UL Cohen's d Total ISTH-BAT 225.00 ± 10.50 235.50 ± 12.50 -4.48 <0.001*** -15.60 -5.40 0.87 Total WHOQOL-BREF 75.50 ± 6.50 72.00 ± 8.00 2.42 0.017* 0.65 6.35 0.46 Note. Values are presented as Mean ± Standard Deviation; Independent samples t-tests were conducted to compare participants of both male and female groups; Group sizes are shown as N (%); A p-value < 0.001 was considered statistically significant, N = 300. 130 Juntendo Medical Journal 72(1), 2026 Table 4 Age-related differences in bleeding severity and quality of life among patients (N = 300) Variables 18-29 years (N=40;13.3); (M ± SD) 30-39 years (N=55;18.3); (M ± SD) 40-49 years (N=70;23.3); (M ± SD) 50-59 years (N=80;26.7); (M ± SD) 60+ years (N=55;18.3); F(4,295) (M ± SD) Total International Society on Throm-bosis and Haemo-stasis - Bleeding Assessment Tool (ISTH-BAT) 220.0 ± 8.0 225.0 ± 9.0 230.0 ± 10.0 235.0 ± 11.0 240.0 ± 12.0 Total World Health Organization Quality of Life (WHO­ QOL-BREF) 76.0 ± 6.0 74.0 ± 7.0 72.0 ± 7.5 70.0 ± 8.0 68.0 ± 8.5 p η2 12.30 <0.001*** 0.142 6.30 <0.001*** 0.079 Note. Data are presented as Mean ± Standard Deviation (M ± SD); Group sizes are shown as N (%). One-way ANOVA was conducted to examine the effect. All comparisons were significant at p < 0.001; η2 represents the partial eta-squared effect size. Table 5 Multiple Linear Regression Predicting QOL (WHOQOL-BREF) from bleeding severity, demographics, and clinical factors (N = 300) B SE β t p 95% CI Lower LL 95% CI Upper UL (Constant) 85.000 5.000 - 17.00 <0.001*** 75.200 94.800 Total ISTH-BAT -0.230 0.035 -0.320 -6.57 <0.001*** -0.299 -0.161 Gender (Male=1, Female=2) -2.500 0.900 -0.110 -2.78 0.006** -4.268 -0.732 Age (years) -0.150 0.040 -0.180 -3.75 <0.001*** -0.229 -0.071 Duration since ITP diagnosis (years) -0.250 0.080 -0.120 -3.13 0.002** -0.407 -0.093 Frequency of bleeding episodes (past 6 months) -0.800 0.200 -0.200 -4.00 <0.001*** -1.196 -0.404 Any hospitalisation due to bleeding? -1.800 0.600 -0.130 -3.00 0.003** -2.984 -0.616 Presence of other chronic illness -1.500 0.500 -0.110 -3.00 0.003** -2.480 -0.520 Model Note. Values include unstandardized coefficients (B), 95% confidence intervals (CI), standard errors (SE), standardised beta coefficients (β), and p-values; **= p < 0.01, ***=p < 0.001 were considered statistically significant; N = 300. Figure 1 Bar chart for regression predicting quality of life (WHOQOL-BREF) (N = 300) = -0.110, p = 0.003) were all predictors of lower quality of life. All these aspects indicate the multi­ factorial influence of clinical and demographic factors on patients' well-being. Regression coefficients predicting quality of life (WHOQOL-BREF) Figure 1 shows the regression coefficients (B) standardised to predict QOL, as measured by the WHOQOL-BREF, for 300 patients with immune 131 Popoola M, et al: Bleeding severity and quality of life in ITP thrombocytopenia (ITP). The chart demonstrates a significant negative correlation between higher total ISTH-BAT (bleeding) scores and quality of life, suggesting that more severe bleeding was strongly and negatively associated with patients' well-being. Other independent variables, such as gender, age, years since ITP diagnosis, the number of bleeding episodes in the last six months, hospital­ isation history, and the presence of other chronic conditions, also correlated negatively with quality of life, but the effects were relatively weak. On the whole, bleeding severity turned out to be the most significant predictor of poor quality of life in patients with ITP. Discussion The current study investigated the association between bleeding severity and QoL in adults with ITP in a South Asian clinical setting. Our results showed a significant negative correlation between bleeding severity and QoL, indicating that patients with more severe bleeding have lower overall wellbeing. This is in line with previous research on bleeding symptoms and fear of bleeding as deter­ minants of fatigue, limitations in activity, and social and occupational functioning12). There were also gender-specific differences because the female patients noted a higher level of bleeding and poorer QoL than their male counter­ parts. These findings are consistent with the previous research that has already determined that women with bleeding disorders were more likely to bleed in comparison with menstruation, sex and child­ birth and were more fatigued and emotionally dist­ ressed13, 14). This shows the importance of gender sensitive management in ITP. This highlights the significance of gender sensitive management strat­ egies in ITP. Age was another factor which influenced the degree of bleeding and QoL. The ISTH-bat scores of the older patients were poorer, and their QoL was lower, in accordance with available data showing that older age predisposes older people to severe bleeding and other associated issues15, 16). It is possible to correlate age-related deterioration in quality of life with accumulating disease burden, comorbid conditions, and treatment-related problems. The other significant finding of our study is that, according to regression analysis, bleeding severity, 132 older age, and female gender are potent predictors of lower QoL, consistent with the literature 12, 14, 16). Likewise, lower QoL was associated with increased disease duration and repeated bleeding events, which are manifestations of physical discomfort, anxiety, and lifestyle restriction related to chronic exposure to ITP symptoms and treatment17, 18). The other serious predictor of worse QoL was the extensive bleeding that led to hospitalisation, likely due to the physical, psychological and social turmoil such events created. Further, comorbid chronic illnesses augmented the health burden and further reduced the QoL16, 19). All in all, the findings demonstrate that the inten­ sity of bleeding, gender, age, disease duration, hospi­ talisation, and comorbidities influence QoL in ITP patients. Knowledge of such factors may guide clinicians in providing personalised interventions to mitigate the impact of diseases and improve patients' well-being. Study constraints Several limitations must be noted. First, a crosssectional design does not allow for causal inference between bleeding severity and QOL; longitudinal research is required to determine the direction of causation. Second, convenience sampling was used, limiting generalizability to community settings or other rural populations and potentially introducing selection bias. Third, self-reported instruments were used in data collection and can be subject to recall or response bias. Fourth, the patients were not strat­ ified by treatment phase (newly diagnosed, persistent, or chronic ITP), which could have affected bleeding profiles and QoL outcomes. Finally, the other psycho­ social variables, such as social support and coping techniques, were not quantified but may have medi­ ated the identified relationships. Conclusion The research indicates that bleeding severity is closely linked to QOL in adults with ITP. Patients who have more severe bleeding, repeated hospital­ isations, and comorbidities are more physically and psychologically impaired. These challenges are further aggravated by female gender, old age, and prolonged disease period. The findings indicate that clinicians must adopt a multidimensional approach to treating ITP, extending beyond platelet count to Juntendo Medical Journal 72(1), 2026 consider patients' mental, social, and emotional health. Early detection of bleeding symptoms and active monitoring of HRQoL enable the implementation of a personalised intervention to improve overall patient outcomes.